France to promote sales of generic drugsBMJ 2001; 323 doi: https://doi.org/10.1136/bmj.323.7314.653/a (Published 22 September 2001) Cite this as: BMJ 2001;323:653
- Alexander Dorozynski
The results of a survey released by the French social security administration last week show that only 3.1% of drugs sold in the country are generic drugs.
The government is now proposing legislation to bring the sales of generics closer to the average level in other developed countries, in the hope of saving billions of francs a year.
Sales of drugs account for more than 20% of health costs in France. The social security administration, which reimburses patients all or …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial